PKCβII activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination
Life Science Alliance · 2023
DOI: 10.26508/lsa.202201748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2023. Verfasst von Xiao Min und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Chonnam National University, Gwang-Ju, Republic of Korea. Hauptthemen laut MEDLINE: Actins, Clathrin, Protein Kinase C beta, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Drug Development Fund.
Abstract (Originalsprache)
PKCβII, a conventional PKC family member, plays critical roles in the regulation of a variety of cellular functions. Here, we employed loss-of-function approaches and mutants of PKCβII with altered phosphorylation and protein interaction behaviors to identify the cellular mechanisms underlying the activation of PKCβII. Our results show that 3-phosphoinositide–dependent protein kinase-1 (PDK1)–mediated constitutive phosphorylation of PKCβII at the activation loop (T500) is required for phorbol ester–induced nuclear entry and subsequent Mdm2-mediated ubiquitination of PKCβII, whereas ubiquitination of PKCβII is required for the PDK1-mediated inducible phosphorylation of PKCβII at T500 in the nucleus. After moving out of the nucleus, PKCβII interacts with actin, undergoes inducible mTORC2-mediated phosphorylation at the turn motif (T641), interacts with clathrin, and then translocates to the plasma membrane. This overall cascade of cellular events intertwined with the phosphorylation at critical residues and Mdm2-mediated ubiquitination in the nucleus and along with interactions with actin and clathrin plays roles that encompass the core processes of PKC activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Chonnam National University, Gwang-Ju, Republic of Korea.
- Department of Pharmacology, College of Pharmacy, Chonnam National University, Gwang-Ju, Republic of Korea kmkim@jnu.ac.kr.
ORCID-Profile: Kyeong-Man Kim
Förderung
- National Research Foundation of Korea
- Korea Drug Development Fund
Zitieren
APA
Min, X., Wang, S., Zhang, X., Sun, N., & Kim, K. M. (2023). PKCβII activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination. Life Science Alliance. https://doi.org/10.26508/lsa.202201748
Vancouver
Min X, Wang S, Zhang X, Sun N, Kim KM. PKCβII activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination. Life Science Alliance. 2023. doi:10.26508/lsa.202201748
BibTeX
@article{Min2023,
author = {Min, Xiao and Wang, Shujie and Zhang, Xiaohan and Sun, Ningning and Kim, Kyeong-Man},
title = {PKCβII activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination},
journal = {Life Science Alliance},
year = {2023},
doi = {10.26508/lsa.202201748}
}
EUVIMED